(Alliance News) - London's blue-chips closed little changed on Monday amid a heavy sell-off in global technology stocks, including a 17% drop for chip maker Nvidia. Read More
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. Read More
(Alliance News) - GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment for shingles. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Monday, ahead of a slew of interest rate decisions this week, and as investors continue to track any policy giveaways from the new Donald Trump US administration. Read More
(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or recurrent endometrial cancer eligible for systemic therapy. Read More
(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More
(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorgan Securities on Tuesday. Read More
(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfolio in gastrointestinal cancers". Read More
(Alliance News) - Stock prices in London opened in the red on Monday, after Friday's US jobs data increased expectations of a pause in rate cuts this year. Read More
(Alliance News) - The FTSE 100 was called lower on Monday, after Friday's US jobs data strengthened Federal Reserve hawks' hand and made rate cuts less likely. Read More
(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer. Read More
(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study. Read More
(Alliance News) - London's FTSE 100 is called to open slightly lower on Friday, after emerging from the new year with a hefty rise on Thursday. Read More
(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum's SRA737 clinical-stage cancer treatment. Read More
(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. Read More
(Alliance News) - Stocks were called lower on Friday ahead of the US Fed's preferred inflation gauge, the personal consumption expenditures reading, this afternoon. Read More